Tranylcypromine and bupropion combination therapy in treatment-resistant major depression: A report of 2 cases

Journal of Clinical Psychopharmacology

Volumn 32, Issue 4, 2012, Pages 572-574

  Quante, Arnim ^a   Zeugmann, Sara ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGOMELATINE; AMFEBUTAMONE; AMITRIPTYLINE; ARIPIPRAZOLE; CITALOPRAM; DULOXETINE; ESCITALOPRAM; FLUOXETINE; LITHIUM; MIRTAZAPINE; MODAFINIL; OLANZAPINE; PAROXETINE; PREGABALIN; QUETIAPINE; TRANYLCYPROMINE; VENLAFAXINE;

ABSENCE OF SIDE EFFECTS; ADD ON THERAPY; ADULT; CASE REPORT; COMPARATIVE EFFECTIVENESS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; ELECTROCONVULSIVE THERAPY; HAMILTON SCALE; HUMAN; LETTER; MAJOR DEPRESSION; MALE; MOOD; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; TREATMENT DURATION;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; DRUG THERAPY, COMBINATION; HUMANS; MALE; MIDDLE AGED; MONOAMINE OXIDASE INHIBITORS; TRANYLCYPROMINE;

EID: 84863699417     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31825de0a7     Document Type: Letter

References (4)

1. Rush AJ, Trivedi MH, Wisniewski SR, et al. STAR*D Study Team. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med. 2006;354(12):1231-1242.
2. Kumar S, Kodela S, Detweiler JG, et al. Bupropion-induced psychosis: folklore or a fact? A systematic review of the literature. Gen Hosp Psychiatry. 2011;33(6):612-617.
3. Pierre JM,Gitlin MJ. Bupropion-tranylcypromine combination for treatment-refractory depression. J Clin Psychiatry. 2000;61(6):450-451.
4. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.